Compare ATAI & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATAI | CNMD |
|---|---|---|
| Founded | 2018 | 1970 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2021 | 1987 |
| Metric | ATAI | CNMD |
|---|---|---|
| Price | $4.32 | $40.86 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | $14.00 | ★ $53.67 |
| AVG Volume (30 Days) | ★ 3.6M | 613.8K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 1.96% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.05 |
| Revenue | $3,018,000.00 | ★ $1,347,470,000.00 |
| Revenue This Year | $943.83 | $6.81 |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | ★ N/A | $19.92 |
| Revenue Growth | ★ 811.78 | 4.61 |
| 52 Week Low | $1.15 | $38.32 |
| 52 Week High | $6.75 | $74.75 |
| Indicator | ATAI | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.78 | 43.03 |
| Support Level | $4.25 | $38.32 |
| Resistance Level | $4.54 | $44.98 |
| Average True Range (ATR) | 0.22 | 1.67 |
| MACD | 0.10 | -0.19 |
| Stochastic Oscillator | 71.36 | 37.22 |
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.